35 studies found for:    " July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Behavioral: Tailored Information Program for Safer Sex
2 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
3 Unknown  Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study
Conditions: Acute Hepatitis C;   HIV;   HIV Infections
Intervention:
4 Completed Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
Conditions: Insulin Resistance;   Atherosclerosis;   Cardiovascular Disease;   HIV/AIDS;   HIV Infections
Intervention:
5 Completed
Has Results
Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic
Conditions: HIV;   Sexually Transmitted Diseases;   HIV Infections
Interventions: Behavioral: DVD 1;   Behavioral: DVD 2
6 Withdrawn Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts
Conditions: HIV Infection;   AIDS;   HIV Infections
Intervention:
7 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
8 Active, not recruiting
Has Results
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: efavirenz
9 Unknown  Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Conditions: HIV Transmission;   HIV Infections
Intervention: Drug: tenofovir + emtricitabine, lopinavir/ritonavir
10 Active, not recruiting
Has Results
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572 (Cohort I);   Drug: GSK1349572 (Cohort II)
11 Completed Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
Condition: HIV Infections
Intervention: Drug: Etravirine (Intelence)
12 Completed Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
Condition: HIV Infections
Interventions: Biological: NYVAC-B;   Biological: Placebo;   Biological: rAd5
13 Completed Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Conditions: Herpes Simplex Type Two Infection;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
14 Completed Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
Condition: HIV Infections
Interventions: Behavioral: Referral of Partners;   Behavioral: Screening for STIs and counseling;   Behavioral: Peer health care system navigators;   Behavioral: Enhanced counseling
15 Active, not recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
16 Recruiting Examining Benefits of HAART Continuation in Postpartum Mothers
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
17 Completed Molecular Biology of Anal Cancer in HIV-Positive Patients
Conditions: Carcinoma;   HIV Infections
Intervention:
18 Completed Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC);   Biological: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS);   Procedure: Blood draw
19 Completed
Has Results
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent pneumococcal conjugate vaccine;   Procedure: Blood draw
20 Completed TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains
Condition: HIV Infections
Intervention: Drug: TMC114

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years